Publication
A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma
Journal Paper/Review - Nov 27, 2019
van den Bent Martin, Zhang Hefei, Balbin O Alejandro, Vicente Sergio, Cheng Yi, Kirsilae Tiina, Zhao Sylvia, Tiedt Ralph, Rodón Jordi, Tabatabai Ghazaleh, Jörger Markus, Lassman Andrew B, Wen Patrick Y, Yung W K Alfred, Sepulveda Juan, De Vos Filip, Azaro Analia, Wick Wolfgang
van den Bent, Martin
Azaro, Analia
De Vos, Filip
Sepulveda, Juan
Yung, W K Alfred
Wen, Patrick Y
Lassman, Andrew B
Jörger, Markus
chief of serviceMedizinische Onkologie und Hämatologie · Dept. I